GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity
Conditions
- Morbid Obesity
- Anorectal Diseases
- Drug-Related Side Effects and Adverse Reactions
- Constipation
- Diarrhea
Interventions
- DRUG: GLP-1 receptor agonist therapy
Sponsor
Gazi University